CD73-BLOCKADE

European patent · EP3204417 · In force

Register entry

Publication number
EP3204417
Application number
EP15778310
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 9, 2015
Published
Aug 16, 2017
Granted
Jul 22, 2020
Protection ends at the latest
Oct 8, 2035
Next annual fee due
Oct 31, 2026
IPC classes
C07K 16/28 (2006.01)
C07K 16/40 (2006.01)
C07K 16/30 (2006.01)
Priority
US 201462062323 P 10.10.2014
US 201562118549 P 20.02.2015
US 201562133597 P 16.03.2015
US 201562188881 P 06.07.2015
PCT application
PCT/EP2015/073370 09.10.2015
PCT publication
WO2016/055609 14.04.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 17, 2022

    Change

    Published in Swissreg on 17.11.2022

  5. Jul 22, 2020

    Granted

    Published in Swissreg on 22.07.2020

Parties

Holder

Innate Pharma

117, Avenue de Luminy, 13009 Marseille, FR

Inventor

GAUTHIER, Laurent

F-13008 Marseille, FR

PERROT, Ivan

F-13830 Roquefort La Bedoule, FR

PATUREL, Carine

F-69280 Marcy l'Etoile, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.